Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves first prescription mobile app for opioid use disorder, courtesy of Sandoz and Pear Therapeutics

pharmafileDecember 12, 2018

Tag: OUD , CBT , reSET-O

PharmaSources Customer Service